GREAT POINT PARTNERS LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
GP GREAT POINT PARTNERS LLC | Institutional Filer | ▲ 32.38% | $408.3M | 39 |
Current Portfolio Holdings
Showing all 39 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | APGE | Apogee Therapeutics, Inc. | Healthcare | 374K | $31.5M | 7.71% |
| 2 | VOR | Vor Biopharma Inc. | Healthcare | 1.8M | $31.2M | 7.65% |
| 3 | ZURA | Zura Bio Limited | Healthcare | 4.2M | $25.1M | 6.14% |
| 4 | AMLX | Amylyx Pharmaceuticals, Inc. | Healthcare | 1.8M | $24.3M | 5.96% |
| 5 | NKTR | Nektar Therapeutics | Healthcare | 316K | $22.8M | 5.58% |
| 6 | SLGL | Sol-Gel Technologies Ltd. | Healthcare | 274K | $21.7M | 5.32% |
| 7 | ALMS | Alumis Inc. Common Stock | Healthcare | 856K | $18.9M | 4.62% |
| 8 | DRUG | Bright Minds Biosciences Inc. | Healthcare | 220K | $16.1M | 3.93% |
| 9 | ANNX | Annexon, Inc. | Healthcare | 2.5M | $13.8M | 3.39% |
| 10 | KALV | KalVista Pharmaceuticals, Inc. | Healthcare | 675K | $13.6M | 3.33% |
| 11 | IMVT | Immunovant, Inc. | Healthcare | 546K | $13.6M | 3.32% |
| 12 | JBIO | Jade Biosciences, Inc. | Healthcare | 964K | $13.6M | 3.32% |
| 13 | CTNM | Contineum Therapeutics, Inc. Class A Common Stock | Healthcare | 800K | $10.5M | 2.56% |
| 14 | ZBIO | Zenas BioPharma, Inc. | Healthcare | 524K | $10.2M | 2.51% |
| 15 | NGNE | Neurogene Inc. | Healthcare | 500K | $10.1M | 2.47% |
Showing 1 to 15 of 39 holdings